POMC and neoplasm: This suggests that in patients with tumours that are considered true non-secretors (with a second-day plasma cortisol below 1.8 μg/dL), tumour-associated bone resorption (as indicated by the collagen-derived biomarker) might be reflected by a suppressed baseline ACTH.